Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications

  • Wang L
  • Xu G
  • Spanos M
  • et al.
46Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardiovascular disease is one of the leading causes of mortality worldwide. Recent studies have shown that circular RNAs (circRNAs) have emerged as important players in the prevention and treatment of cardiovascular diseases. circRNAs are a class of endogenous noncoding RNAs that are generated by back-splicing and are involved in many pathophysiological processes. In this review, we outline the current research progress on the regulatory roles of circRNAs in cardiovascular diseases. Further, new technologies and methods available for identifying, validating, synthesizing, and analyzing circRNAs, as well as their applications in therapeutics, are highlighted here. Moreover, we summarize the increasing insights into the potential use of circRNAs as circulating diagnostic and prognostic biomarkers. Finally, we discuss the prospects and challenges of circRNA therapeutic applications for cardiovascular disease therapy, with a particular focus on developing circRNA synthesis and engineering delivery systems.

Cite

CITATION STYLE

APA

Wang, L., Xu, G., Spanos, M., Li, G., Lei, Z., Sluijter, J. P. G., & Xiao, J. (2023). Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications. Research, 6. https://doi.org/10.34133/research.0038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free